Ultromics
Next-generation Echocardiography is here
Oxford, United Kingdom · $113.0M raised
- Headquarters
- Oxford
- Employees
- 51–200
- Business Model
- B2B
- Website
- ultromics.com
- Total Funding
- $113.0M
- Last Round
- $55.0M Series CJul 2025
- Rounds
- 4
About
AI-powered echocardiography analysis platform that diagnoses complex cardiac diseases from routine echo scans.
Summary
Ultromics is an Artificial Intelligence company based in Oxford, United Kingdom. It has raised $113.0M in total across 4 rounds, most recently a $55.0M Series C round in Jul 2025. Investors include Oxford Science Enterprises, BlueCross BlueShield Venture Partners and American Heart Association Ventures.
Tech & App Stack
6 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...